MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-65 Cr | ₹-69 Cr | ₹198 Cr | ₹80 Cr | ₹-15 Cr |
What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-65 Cr |
Mar2024 | ₹-69 Cr |
Mar2023 | ₹198 Cr |
Mar2022 | ₹80 Cr |
Mar2021 | ₹-15 Cr |
How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-65 Cr | Negative | |
Mar2024 | ₹-69 Cr | Negative | |
Mar2023 | ₹198 Cr | 148.81 | |
Mar2022 | ₹80 Cr | Positive | |
Mar2021 | ₹-15 Cr | - |
Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹10,246.9 Cr | -0.6% | -14% | 9.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -0.6% |
-14% |
9.3% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses